AU2003266210A1 - Use of mas-compounds for treating diseases associated with lipid metabolism - Google Patents

Use of mas-compounds for treating diseases associated with lipid metabolism

Info

Publication number
AU2003266210A1
AU2003266210A1 AU2003266210A AU2003266210A AU2003266210A1 AU 2003266210 A1 AU2003266210 A1 AU 2003266210A1 AU 2003266210 A AU2003266210 A AU 2003266210A AU 2003266210 A AU2003266210 A AU 2003266210A AU 2003266210 A1 AU2003266210 A1 AU 2003266210A1
Authority
AU
Australia
Prior art keywords
mas
compounds
diseases associated
treating diseases
lipid metabolism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003266210A
Other versions
AU2003266210A8 (en
Inventor
Christian Grondahl
Bernhard Lindenthal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU2003266210A8 publication Critical patent/AU2003266210A8/en
Publication of AU2003266210A1 publication Critical patent/AU2003266210A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AU2003266210A 2002-09-25 2003-09-23 Use of mas-compounds for treating diseases associated with lipid metabolism Abandoned AU2003266210A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200201417 2002-09-25
DKPA200201417 2002-09-25
PCT/DK2003/000619 WO2004028544A1 (en) 2002-09-25 2003-09-23 Use of mas-compounds for treating diseases associated with lipid metabolism

Publications (2)

Publication Number Publication Date
AU2003266210A8 AU2003266210A8 (en) 2004-04-19
AU2003266210A1 true AU2003266210A1 (en) 2004-04-19

Family

ID=32039048

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003266210A Abandoned AU2003266210A1 (en) 2002-09-25 2003-09-23 Use of mas-compounds for treating diseases associated with lipid metabolism

Country Status (2)

Country Link
AU (1) AU2003266210A1 (en)
WO (1) WO2004028544A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2558766A1 (en) 2004-03-05 2005-09-22 The Trustees Of The University Of Pennsylvania The use of mtp inhibitors for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side effects

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506354A (en) * 1985-09-12 1996-04-09 The Upjohn Company Imidazolylpiperazinyl steroids
US4939134A (en) * 1988-09-19 1990-07-03 New York University 26-aminocholesterol and derivatives and analogs thereof in the regulation of cholesterol accumulation in body tissue
JPH0491026A (en) * 1990-08-06 1992-03-24 Green Cross Corp:The Fat emulsion containing vegetable sterol

Also Published As

Publication number Publication date
WO2004028544A1 (en) 2004-04-08
AU2003266210A8 (en) 2004-04-19

Similar Documents

Publication Publication Date Title
AU2003239568A1 (en) Pyrrolotriazinone compounds and their use to treat diseases
IL165820A0 (en) Diphenylazetidinone derivatives for treating disorders of the lipid metabolism
AU2003279338A1 (en) Phenethanolamine derivatives for the treatment of respiratory diseases
AU2003286567A1 (en) Methods for the treatment of skin disorders
ZA200707934B (en) Thereapeutic formulations for the treatment of beta-amyloid related diseases
AU2003261251A1 (en) Methods of delivering therapeutic agents
AU2003238011A1 (en) Treating vitamin d responsive diseases
AU2002343739A1 (en) Improved therapy for topical diseases
AU2003228819A1 (en) Combinations for the treatment of inflammatory skin disorders
AU2003286728A1 (en) Compounds for the treatment of metabolic disorders
AUPS160602A0 (en) Therapeutic method
AU2001232787A1 (en) Airway alkalinization as therapy for airway diseases
AU2003223684A1 (en) Lxr modulators for the treatment of cardiovascular diseases
AU2003290939A1 (en) Replication of biological tiussue
AU2003223538A1 (en) Methods for the treatment of cancer
AU2003230004A1 (en) Methods of therapy for inducing tolerance
AU2003240545A1 (en) Use of ramoplanin to treat diseases associated with the use of antibiotics
AU2003266210A1 (en) Use of mas-compounds for treating diseases associated with lipid metabolism
AU2003262264A1 (en) Agent for reducing side effects of diclofenac
AU2003295504A1 (en) Development of therapeutics for the treatment of endotoxin-mediated diseases
AU2003232844A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
AU2003279461A1 (en) Disorders of lipid metabolism
AU2003298080A1 (en) Human lipid phosphate phosphatases and uses thereof for treating neuronal diseases
AU2002253708A1 (en) Hyperbaric chamber for the treatment of diabetic foot
AU2003293581A1 (en) Method of identifying therapeutic agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase